scholarly journals Copper-Catalyzed Aerobic Oxidations of Organic Molecules: Pathways for Two-Electron Oxidation with a Four-Electron Oxidant and a One-Electron Redox-Active Catalyst

2015 ◽  
Vol 48 (6) ◽  
pp. 1756-1766 ◽  
Author(s):  
Scott D. McCann ◽  
Shannon S. Stahl
Author(s):  
Youngjin Ham ◽  
Nathan J. Fritz ◽  
Gayea Hyun ◽  
Young Bum Lee ◽  
Jong Seok Nam ◽  
...  

Organic molecules with redox-active motifs are of great interest for next-generation electrodes for sustainable energy storage. While there has been significant progress in designing redox-active molecules, the practical requirements of...


2020 ◽  
Vol 8 (31) ◽  
pp. 15715-15724 ◽  
Author(s):  
Jingchao Chai ◽  
Amir Lashgari ◽  
Xiao Wang ◽  
Caroline K. Williams ◽  
Jianbing “Jimmy” Jiang

A non-aqueous redox flow battery based on all-PEGylated, metal-free compounds is presented. The PEGylation enhances the stability of the redox-active materials, alleviating crossover by increasing the anolyte and catholyte species’ molecular sizes.


2018 ◽  
Vol 6 (15) ◽  
pp. 6251-6254 ◽  
Author(s):  
Jinhua Huang ◽  
Wentao Duan ◽  
Jingjing Zhang ◽  
Ilya A. Shkrob ◽  
Rajeev S. Assary ◽  
...  

Understanding structure–property relationships is essential for designing energy-rich redox active organic molecules (ROMs) for all-organic redox flow batteries.


Molecules ◽  
2018 ◽  
Vol 23 (9) ◽  
pp. 2253 ◽  
Author(s):  
Tiffany Rundstadler ◽  
Arvin Eskandari ◽  
Sarah Norman ◽  
Kogularamanan Suntharalingam

Cancer stem cells (CSCs) are thought of as a clinically pertinent subpopulation of tumors, partly responsible for cancer relapse and metastasis. Research programs aimed at discovering anti-CSC agents have largely focused on biologics and purely organic molecules. Recently, we showed that a family of redox-active copper(II) complexes with phenanthroline-based ligands and nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin, are capable of potently and selectively killing breast CSCs. Herein we present analogous redox-inactive, zinc(II)-phenanthroline-indomethacin complexes with the ability to kill breast CSCs and bulk breast cancer cells with equal potency (in the submicro- or micromolar range). A single dose of the zinc(II) complexes could theoretically be administered to eliminate whole tumor populations. Excitingly, some of the zinc(II) complexes decrease the growth and viability of mammospheres to a comparable or higher degree than salinomycin, a compound known to effectively kill breast CSCs. As far as we are aware this is the first report to examine the anti-breast CSC activity of zinc(II)-containing compounds.


2021 ◽  
Author(s):  
Ying Hua ◽  
Yuanzhu Huang ◽  
Yujie Wang ◽  
Ya Du ◽  
Haishen Yang

Due to their readily availability and high capacity, redox-active small organic molecules have been considered as one of the most promising electrode materials. However, their facile dissolution into organic electrolytes...


Sign in / Sign up

Export Citation Format

Share Document